factory customized Tribenzoate - 7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one CAS 160129-45-3 Tolvaptan Intermediate – Ruifu
factory customized Tribenzoate - 7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one CAS 160129-45-3 Tolvaptan Intermediate – Ruifu Detail:
Manufacturer Supply High Quality, Commercial Production
Chemical Name: 7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one
CAS: 160129-45-3
Chemical Name | 7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one |
Synonyms | 7-Chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one; 7-Chloro-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one |
CAS Number | 160129-45-3 |
CAT Number | RF-PI395 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C10H10ClNO |
Molecular Weight | 195.65 |
Melting Point | 103.0 to 107.0℃ |
Solubility | Soluble in Methanol |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | Light Green to Light Yellow Powder |
Identification Methods | NMR, HPLC |
Purity / Analysis Method | ≥99.0% (HPLC) |
Loss on Drying | ≤1.0% |
Residue on Ignition | ≤0.50% |
Any Single Impurity | ≤0.50% |
Total Impurities | ≤1.0% |
Test Standard | Enterprise Standard |
Usage | Intermediate of Tolvaptan (CAS 150683-30-0), treatment of Hyponatremia |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one (CAS 160129-45-3) is an intermediate in the synthesis of Tolvaptan (CAS 150683-30-0). Tolvaptan is a selective, competitive orally active nonpeptide arginine vasopressin V2 receptor antagonist with an IC50 of 1.28µM for the inhibition of AVP-induced platelet aggregation. Tolvaptan is used to treat hyponatremia associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone. Tolvaptan is also in fast-track clinical trials for polycystic kidney disease. Treatment with Tolvaptan causes rapid and sustained body weight reductions concurrent with increases in urine output, improves and/or normalizes serum sodium in hyponatremic patients, reduces signs and symptoms of congestion and increases thirst.
Product detail pictures:
Related Product Guide:
factory customized Tribenzoate - 7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one CAS 160129-45-3 Tolvaptan Intermediate – Ruifu , The product will supply to all over the world, such as: , , ,
By from -
By from -